-
Sanofi: Cutting Three Pipeline Programs
Sanofi
In Q3 2024, Sanofi reported a 15.7% increase in sales to €13.4 billion, driven by vaccine sales. The company removed three studies from its pipeline while achieving key regulatory approvals and positive trial results for several products, including Dupixent.
-
-
-
-
-
-
-
-
-
开鲁县|
柏乡县|
扎囊县|
通海县|
临邑县|
泗阳县|
洛川县|
古蔺县|
绥化市|
同心县|
建阳市|
西贡区|
慈溪市|
巴中市|
高阳县|
德州市|
平塘县|
襄汾县|
夏津县|
亚东县|
庆安县|
长垣县|
南华县|
乐东|
义乌市|
中江县|
轮台县|
葫芦岛市|
万宁市|
正宁县|
SHOW|
如东县|
濮阳市|
双流县|
普兰县|
达尔|
沈阳市|
丽水市|
上栗县|
齐河县|
洪江市|